$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams

$ams Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000143774923031902 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$5.698M	$5.134M	$4.828M
YoY Change	13.12%	6.34%	17.78%
Cost Of Revenue	$2.882M	$3.032M	$2.871M
YoY Change	4.16%	5.61%	9.08%
Gross Profit	$2.816M	$2.102M	$1.957M
YoY Change	24.05%	7.41%	33.4%
Gross Profit Margin	49.42%	40.94%	40.53%
Selling, General & Admin	$1.760M	$1.735M	$1.260M
YoY Change	23.94%	37.7%	12.6%
% of Gross Profit	62.5%	82.54%	64.38%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.295M	$1.265M	$1.182M
YoY Change	5.63%	7.02%	-4.75%
% of Gross Profit	45.99%	60.18%	60.4%
Operating Expenses	$1.760M	$1.735M	$1.260M
YoY Change	23.94%	37.7%	12.6%
Operating Profit	$1.056M	$90.00K	$448.0K
YoY Change	24.24%	-79.91%	140.86%
Interest Expense	-$179.0K	$277.0K	$249.0K
YoY Change	-12.25%	11.24%	53.7%
% of Operating Profit	-16.95%	307.78%	55.58%
Other Income/Expense, Net
YoY Change
Pretax Income	$515.0K	$225.0K	$484.0K
YoY Change	-20.28%	-53.51%	161.62%
Income Tax	$338.0K	$60.00K	$176.0K
% Of Pretax Income	65.63%	26.67%	36.36%
Net Earnings	$415.0K	$118.0K	$316.0K
YoY Change	68.7%	-62.66%	857.58%
Net Earnings / Revenue	7.28%	2.3%	6.55%
Basic Earnings Per Share		$0.02	$0.05
Diluted Earnings Per Share	$0.06	$0.02	$0.05
COMMON SHARES
Basic Shares Outstanding	6.300M	6.244M	6.112M
Diluted Shares Outstanding		6.432M	6.273M

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$13.69M	$14.54M	$11.55M
YoY Change	10.99%	25.93%	63.77%
Cash & Equivalents	$13.69M	$14.54M	$11.55M
Short-Term Investments
Other Short-Term Assets	$1.919M	$1.200M	$1.150M
YoY Change	-15.09%	4.35%	-41.03%
Inventory
Prepaid Expenses
Receivables	$4.343M	$3.986M	$3.550M
Other Receivables	$504.0K	$651.0K	$582.0K
Total Short-Term Assets	$20.46M	$20.37M	$16.83M
YoY Change	9.26%	21.05%	22.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$25.92M	$25.29M	$25.15M
YoY Change	8.89%	0.56%	-13.1%
Goodwill	$1.265M	$1.265M	$1.265M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$78.00K	$78.00K	$78.00K
YoY Change	0.0%	0.0%	0.0%
Long-Term Investments
YoY Change
Other Assets	$443.0K	$353.0K	$88.00K
YoY Change	409.2%	301.14%	22.22%
Total Long-Term Assets	$27.71M	$26.99M	$26.58M
YoY Change	9.8%	1.53%	-12.44%
TOTAL ASSETS
Total Short-Term Assets	$20.46M	$20.37M	$16.83M
Total Long-Term Assets	$27.71M	$26.99M	$26.58M
Total Assets	$48.16M	$47.36M	$43.41M
YoY Change	9.57%	9.1%	-1.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$315.0K	$346.0K	$270.0K
YoY Change	36.96%	28.15%	-2.53%
Accrued Expenses	$2.040M	$2.810M	$1.888M
YoY Change	-20.65%	48.83%	-23.16%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.584M	$1.459M	$1.262M
YoY Change	263.23%	15.61%	16.74%
Total Short-Term Liabilities	$10.78M	$10.05M	$4.264M
YoY Change	108.29%	135.67%	-6.94%
LONG-TERM LIABILITIES
Long-Term Debt	$11.04M	$10.45M	$12.62M
YoY Change	-9.54%	-17.14%	-14.37%
Other Long-Term Liabilities	$0.00	$30.00K	$181.0K
YoY Change	-100.0%	-83.43%	-64.3%
Total Long-Term Liabilities	$11.04M	$10.45M	$12.62M
YoY Change	-9.54%	-17.14%	-14.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.78M	$10.05M	$4.264M
Total Long-Term Liabilities	$11.04M	$10.45M	$12.62M
Total Liabilities	$25.54M	$21.35M	$17.98M
YoY Change	39.32%	18.75%	-6.9%
SHAREHOLDERS EQUITY
Retained Earnings	$3.629M	$3.214M	$2.773M
YoY Change	20.21%	15.9%	88.38%
Common Stock	$19.00M	$18.90M	$18.44M
YoY Change	2.09%	2.47%	1.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$22.62M	$22.11M	$21.22M
YoY Change
Total Liabilities & Shareholders Equity	$48.16M	$47.36M	$43.41M
YoY Change	9.57%	9.1%	-1.67%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	$415.0K	$118.0K	$316.0K
YoY Change	68.7%	-62.66%	857.58%
Depreciation, Depletion And Amortization	$1.295M	$1.265M	$1.182M
YoY Change	5.63%	7.02%	-4.75%
Cash From Operating Activities	-$3.062M	$3.570M	$1.541M
YoY Change	-291.14%	131.67%	-325.29%
INVESTING ACTIVITIES
Capital Expenditures	$93.00K	$3.620M	-$236.0K
YoY Change	66.07%	-1633.9%	100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$93.00K	-$3.620M	-$236.0K
YoY Change	66.07%	1433.9%	100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.310M	910.0K	-1.608M
YoY Change	-405.15%	-156.59%	244.33%
NET CHANGE
Cash From Operating Activities	-3.062M	3.570M	1.541M
Cash From Investing Activities	-93.00K	-3.620M	-236.0K
Cash From Financing Activities	2.310M	910.0K	-1.608M
Net Change In Cash	-845.0K	860.0K	-303.0K
YoY Change	-207.1%	-383.83%	-76.12%
FREE CASH FLOW
Cash From Operating Activities	-$3.062M	$3.570M	$1.541M
Capital Expenditures	$93.00K	$3.620M	-$236.0K
Free Cash Flow	-$3.155M	-$50.00K	$1.777M
YoY Change	-304.08%	-102.81%	-413.96%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	ams	Property Plant And Equipment Net Excluding Land PropertyPlantAndEquipmentNetExcludingLand	25178000	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6270000
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6270000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6184000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6184000
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	94000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P4Y
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-08789
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CA
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-2918118
	dei	Entity Address Address Line1 EntityAddressAddressLine1	601 Montgomery Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94111-2619
	dei	City Area Code CityAreaCode	415
	dei	Local Phone Number LocalPhoneNumber	788-5300
	dei	Security12b Title Security12bTitle	American Shared Hospital Services Common Stock, No Par Value
	dei	Trading Symbol TradingSymbol	AMS
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6300000
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14537000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12335000	usd
CY2023Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	118000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	118000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3986000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3801000	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	651000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	327000	usd
CY2023Q3	ams	Prepaid Maintenance Current PrepaidMaintenanceCurrent	832000	usd
CY2022Q4	ams	Prepaid Maintenance Current PrepaidMaintenanceCurrent	1245000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	247000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	897000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	20371000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	18723000	usd
CY2022Q4	ams	Property Plant And Equipment Net Excluding Land PropertyPlantAndEquipmentNetExcludingLand	23467000	usd
CY2023Q3	us-gaap	Land Land	19000	usd
CY2022Q4	us-gaap	Land Land	19000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	1265000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1265000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	78000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	78000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	94000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	317000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	353000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	87000	usd
CY2023Q3	us-gaap	Assets Assets	47358000	usd
CY2022Q4	us-gaap	Assets Assets	43956000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	346000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	230000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	805000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	735000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1921000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1544000	usd
CY2023Q3	ams	Asset Retirement Obligation Related Party Current AssetRetirementObligationRelatedPartyCurrent	938000	usd
CY2022Q4	ams	Asset Retirement Obligation Related Party Current AssetRetirementObligationRelatedPartyCurrent	360000	usd
CY2023Q3	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	309000	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	255000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	83000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	292000	usd
CY2023Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1400000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	1459000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1262000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	10049000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5175000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	59000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	10454000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12205000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	18000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	70000	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	822000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	822000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	21354000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	18331000	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	10763000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10763000	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8134000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7843000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3214000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3019000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	22111000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	21625000	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	3893000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	4000000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26004000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25625000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	47358000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43956000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5134000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4828000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15627000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14709000	usd
CY2023Q3	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	518000	usd
CY2022Q3	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	472000	usd
	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	1509000	usd
	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	1374000	usd
CY2023Q3	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	1228000	usd
CY2022Q3	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	1171000	usd
	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	3812000	usd
	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	3514000	usd
CY2023Q3	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1095000	usd
CY2022Q3	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	956000	usd
	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	2997000	usd
	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	2889000	usd
CY2023Q3	ams	Other Cost Of Operating Revenue Related Party OtherCostOfOperatingRevenueRelatedParty	191000	usd
CY2022Q3	ams	Other Cost Of Operating Revenue Related Party OtherCostOfOperatingRevenueRelatedParty	272000	usd
	ams	Other Cost Of Operating Revenue Related Party OtherCostOfOperatingRevenueRelatedParty	781000	usd
	ams	Other Cost Of Operating Revenue Related Party OtherCostOfOperatingRevenueRelatedParty	820000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	3032000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	2871000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	9099000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	8597000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	2102000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	1957000	usd
	us-gaap	Gross Profit GrossProfit	6528000	usd
	us-gaap	Gross Profit GrossProfit	6112000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1735000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1260000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5262000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3725000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	277000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	249000	usd
	us-gaap	Interest Expense InterestExpense	825000	usd
	us-gaap	Interest Expense InterestExpense	546000	usd
CY2023Q3	ams	Write Down Of Impaired Assets And Associated Removal Costs WriteDownOfImpairedAssetsAndAssociatedRemovalCosts	0	usd
CY2022Q3	ams	Write Down Of Impaired Assets And Associated Removal Costs WriteDownOfImpairedAssetsAndAssociatedRemovalCosts	0	usd
	ams	Write Down Of Impaired Assets And Associated Removal Costs WriteDownOfImpairedAssetsAndAssociatedRemovalCosts	578000	usd
	ams	Write Down Of Impaired Assets And Associated Removal Costs WriteDownOfImpairedAssetsAndAssociatedRemovalCosts	0	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	90000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	448000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-137000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1841000	usd
CY2023Q3	ams	Interest And Other Income Loss InterestAndOtherIncomeLoss	135000	usd
CY2022Q3	ams	Interest And Other Income Loss InterestAndOtherIncomeLoss	36000	usd
	ams	Interest And Other Income Loss InterestAndOtherIncomeLoss	318000	usd
	ams	Interest And Other Income Loss InterestAndOtherIncomeLoss	31000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	225000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	484000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	181000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1872000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25741000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	60000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	176000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	93000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	630000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	165000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	308000	usd
	us-gaap	Profit Loss ProfitLoss	88000	usd
	us-gaap	Profit Loss ProfitLoss	1242000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	47000	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-107000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	160000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	118000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	316000	usd
	us-gaap	Net Income Loss NetIncomeLoss	195000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1082000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6366000
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6234000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6336000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6223000
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6432000
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6273000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6406000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6261000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24239000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	87000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	394000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24720000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	72000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	540000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25337000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	76000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	294000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	308000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25427000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25625000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	96000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	100000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25821000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	97000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-177000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	98000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	165000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26004000	usd
	us-gaap	Profit Loss ProfitLoss	88000	usd
	us-gaap	Profit Loss ProfitLoss	1242000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3874000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3557000	usd
	ams	Write Down Of Impaired Assets And Associated Removal Costs WriteDownOfImpairedAssetsAndAssociatedRemovalCosts	578000	usd
	ams	Write Down Of Impaired Assets And Associated Removal Costs WriteDownOfImpairedAssetsAndAssociatedRemovalCosts	0	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	44000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	65000	usd
	ams	Noncash Lease Expense NoncashLeaseExpense	223000	usd
	ams	Noncash Lease Expense NoncashLeaseExpense	252000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	443000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	291000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	235000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	8000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	23000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	498000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-692000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-799000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-998000	usd
	ams	Increase Decrease In Asset Retirement Obligations Related Party IncreaseDecreaseInAssetRetirementObligationsRelatedParty	578000	usd
	ams	Increase Decrease In Asset Retirement Obligations Related Party IncreaseDecreaseInAssetRetirementObligationsRelatedParty	-427000	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	2291000	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-924000	usd
	ams	Increase Decrease In Accounts Payable Accrued Liabilities And Deferred Revenue IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue	713000	usd
	ams	Increase Decrease In Accounts Payable Accrued Liabilities And Deferred Revenue IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue	-220000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	54000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	usd
	ams	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-265000	usd
	ams	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-303000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8778000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5633000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6176000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	332000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6176000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-332000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1589000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1602000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1400000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	202000	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	-0	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	-0	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	294000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	9000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	9000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-400000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1900000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2202000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3401000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12453000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8263000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14655000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11664000	usd
	us-gaap	Interest Paid Net InterestPaidNet	781000	usd
	us-gaap	Interest Paid Net InterestPaidNet	481000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	277000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	174000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14537000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11546000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	118000	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	118000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14655000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11664000	usd
CY2023Q3	ams	Number Of Medical Centers NumberOfMedicalCenters	11	pure
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5134000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4828000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15627000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14709000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	118000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	316000	usd
	us-gaap	Net Income Loss NetIncomeLoss	195000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1082000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;"><b>Reclassification</b> - Certain comparative balances as of and for the <em style="font: inherit;">three</em> and <em style="font: inherit;">nine</em>-month periods ended <em style="font: inherit;"> September 30, 2022</em> have been reclassified to make them consistent with the current year presentation. </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p>
CY2023Q3	us-gaap	Depreciation Depreciation	1265000	usd
	us-gaap	Depreciation Depreciation	3874000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	1182000	usd
	us-gaap	Depreciation Depreciation	3557000	usd
CY2023Q2	ams	Write Down Of Impaired Assets And Associated Removal Costs WriteDownOfImpairedAssetsAndAssociatedRemovalCosts	578000	usd
CY2023Q3	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	0	usd
CY2023Q2	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	578000	usd
CY2023Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	79620000	usd
CY2022Q4	ams	Property Plant And Equipment Gross Excluding Land PropertyPlantAndEquipmentGrossExcludingLand	74237000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	54442000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	50770000	usd
CY2023Q3	ams	Property Plant And Equipment Net Excluding Land PropertyPlantAndEquipmentNetExcludingLand	25178000	usd
CY2022Q4	ams	Property Plant And Equipment Net Excluding Land PropertyPlantAndEquipmentNetExcludingLand	23467000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	44000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	65000	usd
CY2023Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	163000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	198000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	11913000	usd
CY2023Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	163000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	55000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2094000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2469000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	7294000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	164000	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	12076000	usd
CY2023Q3	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	0	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	591000	usd
CY2023Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	291000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	92000	usd
CY2023Q3	ams	Accrued Operating Costs Current AccruedOperatingCostsCurrent	782000	usd
CY2022Q4	ams	Accrued Operating Costs Current AccruedOperatingCostsCurrent	539000	usd
CY2023Q3	ams	Accrued Liabilites Other Current AccruedLiabilitesOtherCurrent	848000	usd
CY2022Q4	ams	Accrued Liabilites Other Current AccruedLiabilitesOtherCurrent	322000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1921000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1544000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P14Y
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	94000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	38000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	59000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	97000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	94000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	59000	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	102000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	265000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	303000	usd
CY2023Q3	us-gaap	Sublease Income SubleaseIncome	30000	usd
CY2022Q3	us-gaap	Sublease Income SubleaseIncome	43000	usd
	us-gaap	Sublease Income SubleaseIncome	129000	usd
	us-gaap	Sublease Income SubleaseIncome	129000	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	29000	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	59000	usd
	us-gaap	Lease Cost LeaseCost	136000	usd
	us-gaap	Lease Cost LeaseCost	174000	usd
CY2023Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	59000	usd
CY2022Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	102000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	265000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	303000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y10M20D
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M18D
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y10M20D
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M18D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0499	pure
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0571	pure
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0499	pure
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0571	pure
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	118000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	316000	usd
	us-gaap	Net Income Loss NetIncomeLoss	195000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1082000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6366000
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6234000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6336000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6223000
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	66000
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	39000
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	70000
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	38000
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6432000
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6273000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6406000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6261000
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	98000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	291000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	76000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	235000	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	164000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	95000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.76
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M29D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	25000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	70000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.82
	ams	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm	P7Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	19000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.69
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	146000
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.8
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	38000
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.86
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	67000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.72
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M29D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	50000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.72
	ams	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm	P5Y
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.7
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	7000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.58
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	108000
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.73
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y10M6D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	9000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	50000
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.74
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y8M26D

Files In Submission

Name	View Source	Status
0001437749-23-031902-index-headers.html	Edgar Link	pending
0001437749-23-031902-index.html	Edgar Link	pending
0001437749-23-031902.txt	Edgar Link	pending
0001437749-23-031902-xbrl.zip	Edgar Link	pending
ams-20230930.xsd	Edgar Link	pending
asha20230930_10q.htm	Edgar Link	pending
ex_565625.htm	Edgar Link	pending
ex_565626.htm	Edgar Link	pending
ex_565627.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
ams-20230930_def.xml	Edgar Link	unprocessable
ams-20230930_cal.xml	Edgar Link	unprocessable
ams-20230930_lab.xml	Edgar Link	unprocessable
ams-20230930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
asha20230930_10q_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams

2023 Q4 Form 10-Q Financial Statement

#000143774923031902 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMS AMERICAN SHARED HOSPITAL SERVICES Stock $ams

2023 Q4 Form 10-Q Financial Statement

#000143774923031902 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams